← Back to All US Stocks

AIBT Stock Analysis - AIBOTICS, INC. AI Rating

AIBT OTC Medicinal Chemicals & Botanical Products NV CIK: 0001763329
Analysis Date: Mar 19, 2026 | Data as of: 2025-09-30
AI Rating
STRONG SELL
95% Confidence

Investment Thesis

Aibotics is a non-viable business with catastrophic financial deterioration and zero operational momentum. The company generated only $2.2K in revenue while burning $1.6M in net losses and $371.6K in operating cash outflows, indicating no viable revenue model or path to profitability. With negative stockholders' equity of -$3.9M, liabilities exceeding assets by 4.8x, and a current ratio of 0.05x, the company faces imminent insolvency and is operationally insolvent.

AIBT Strengths

  • + Positive gross margin at 100% on minimal revenue indicates products sold generate full margins

AIBT Risks

  • ! Negative stockholders equity of -$3.9M indicates technical insolvency
  • ! Revenue of only $2.2K with operating losses of $1.4M demonstrates no viable business model
  • ! Current ratio of 0.05x with liabilities 4.8x assets indicates acute liquidity crisis and default risk
  • ! Negative operating cash flow of -$371.6K with zero capex indicates cash burn with no reinvestment
  • ! ROA of -158.1% and operating margin of -62,776% show severe operational dysfunction
  • ! No insider activity in 90 days suggests loss of management confidence
  • ! Cash position of $230.5K insufficient to cover monthly burn rate

Key Metrics to Watch

AIBT Financial Metrics

Revenue
$2.2K
Net Income
$-1.6M
EPS (Diluted)
$0.00
Free Cash Flow
$-371.6K
Total Assets
$1.0M
Cash Position
$230.5K

AIBT Profitability Ratios

Gross Margin 100.0%
Operating Margin -62,776.4%
Net Margin -73,635.7%
ROE N/A
ROA -158.1%
FCF Margin -17,024.1%

AIBT Balance Sheet & Liquidity

Current Ratio
0.05x
Quick Ratio
0.05x
Debt/Equity
N/A
Debt/Assets
482.1%
Interest Coverage
-8.24x
Long-term Debt
N/A

AIBT 5-Year Financial Trend

AIBT 5-year financial data: Year 2019: Revenue $0, Net Income N/A, EPS N/A. Year 2020: Revenue $0, Net Income N/A, EPS N/A.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: AIBOTICS, INC.'s revenue has remained relatively flat over the 5-year period, with a 0% decline.

AIBT Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-17,024.1%
Free cash flow / Revenue

AIBT Quarterly Performance

Quarterly financial performance data for AIBOTICS, INC. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 N/A -$425.9K N/A
Q2 2025 N/A -$425.9K N/A
Q1 2025 N/A -$425.9K N/A
Q3 2019 $3.3M N/A N/A
Q2 2019 $3.4M N/A N/A

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

AIBT Capital Allocation

Operating Cash Flow
-$371.6K
Cash generated from operations
Dividends
None
No dividend program

AIBT SEC Filings

Access official SEC EDGAR filings for AIBOTICS, INC. (CIK: 0001763329)

📄 10-K Annual Reports 📋 10-Q Quarterly Reports 📰 8-K Current Reports 📊 Proxy Statements 🔍 All Filings

Related Stock Analysis

TFX
TELEFLEX INC
STRONG SELL
NWL
NEWELL BRANDS INC.
STRONG SELL
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 19, 2026 | Data as of: 2025-09-30 | Powered by Claude AI